The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concordance of KRAS mutation detection between illumina next generation gene sequencing (NGS) and CLIA-approved, clinical assays in metastatic colorectal cancer (mCRC).
Nishi Kothari
No relevant relationships to disclose
Timothy Joseph Yeatman
No relevant relationships to disclose
Michael J. Schell
No relevant relationships to disclose
Danielle Greenawalt
Employment or Leadership Position - Merck
James Hardwick
Employment or Leadership Position - Merck
Michael Nebozhyn
Employment or Leadership Position - Merck
Andrey Loboda
Employment or Leadership Position - Merck
Hongyue Dai
Employment or Leadership Position - Merck
Richard D. Kim
No relevant relationships to disclose